Zimmer Biomet Holdings (ZBH) sets cautious expectations for 2026 at the J.P. Morgan Healthcare Conference due to internal changes. Revenue growth estimates remain stable despite weaker demand in Latin America and Eastern Europe. Analysts raise price targets, highlighting potential growth opportunities in 2026. Company focuses on orthopedic, spine, dental, and surgical products worldwide.

Read more at Yahoo Finance: Zimmer Biomet Holdings (ZBH)’s 2026 Expectations Remain Cautious Amid Internal Reset